Cargando…

Cell death in sepsis: a matter of how, when, and where

Dysregulated cell death in several tissues is intimately involved in the pathogenesis of sepsis and contributes to multiple organ failure. Whether cell death during sepsis occurs by necrosis or apoptosis may depend on the cell type as well as the disease stage and is therefore a matter of intense de...

Descripción completa

Detalles Bibliográficos
Autores principales: Bantel, Heike, Schulze-Osthoff, Klaus
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750164/
https://www.ncbi.nlm.nih.gov/pubmed/19678906
http://dx.doi.org/10.1186/cc7966
_version_ 1782172217691340800
author Bantel, Heike
Schulze-Osthoff, Klaus
author_facet Bantel, Heike
Schulze-Osthoff, Klaus
author_sort Bantel, Heike
collection PubMed
description Dysregulated cell death in several tissues is intimately involved in the pathogenesis of sepsis and contributes to multiple organ failure. Whether cell death during sepsis occurs by necrosis or apoptosis may depend on the cell type as well as the disease stage and is therefore a matter of intense debate. While lymphocyte apoptosis contributes to immunosuppression in sepsis, recent evidence suggests that necrosis of hepatocytes predominates in septic patients with liver dysfunction and correlates with poor survival. These distinct modes of cell death might have different consequences for the inflammatory response but are also critical for therapeutic interventions and the disease outcome. Understanding the complexity of death processes employing recently available serum biomarkers of cell death could lead to novel therapeutic approaches and assist in the steering of sepsis treatment.
format Text
id pubmed-2750164
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27501642010-07-31 Cell death in sepsis: a matter of how, when, and where Bantel, Heike Schulze-Osthoff, Klaus Crit Care Commentary Dysregulated cell death in several tissues is intimately involved in the pathogenesis of sepsis and contributes to multiple organ failure. Whether cell death during sepsis occurs by necrosis or apoptosis may depend on the cell type as well as the disease stage and is therefore a matter of intense debate. While lymphocyte apoptosis contributes to immunosuppression in sepsis, recent evidence suggests that necrosis of hepatocytes predominates in septic patients with liver dysfunction and correlates with poor survival. These distinct modes of cell death might have different consequences for the inflammatory response but are also critical for therapeutic interventions and the disease outcome. Understanding the complexity of death processes employing recently available serum biomarkers of cell death could lead to novel therapeutic approaches and assist in the steering of sepsis treatment. BioMed Central 2009 2009-07-31 /pmc/articles/PMC2750164/ /pubmed/19678906 http://dx.doi.org/10.1186/cc7966 Text en Copyright ©2009 BioMed Central Ltd
spellingShingle Commentary
Bantel, Heike
Schulze-Osthoff, Klaus
Cell death in sepsis: a matter of how, when, and where
title Cell death in sepsis: a matter of how, when, and where
title_full Cell death in sepsis: a matter of how, when, and where
title_fullStr Cell death in sepsis: a matter of how, when, and where
title_full_unstemmed Cell death in sepsis: a matter of how, when, and where
title_short Cell death in sepsis: a matter of how, when, and where
title_sort cell death in sepsis: a matter of how, when, and where
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750164/
https://www.ncbi.nlm.nih.gov/pubmed/19678906
http://dx.doi.org/10.1186/cc7966
work_keys_str_mv AT bantelheike celldeathinsepsisamatterofhowwhenandwhere
AT schulzeosthoffklaus celldeathinsepsisamatterofhowwhenandwhere